Resveratrol downregulates Akt/GSK and ERK signalling pathways in OVCAR-3 ovarian cancer cells (Q39414212)

11 September 2017

title

Resveratrol downregulates Akt/GSK and ERK signalling pathways in OVCAR-3 ovarian cancer cells (English)

1 reference

11 September 2017

1 reference

5

1 reference

11 September 2017

12

1 reference

11 September 2017

Pasquale Simeone

2

0 references

Angelo Santino

Angelo Santino

13

0 references

Saverio Alberti

Saverio Alberti

10

0 references

Andrea Tinelli

Andrea Tinelli

8

0 references

Damiana Pieragostino

Damiana Pieragostino

7

0 references

Stefania De Domenico

Stefania De Domenico

9

0 references

Daniele Vergara

Daniele Vergara

1

0 references

Stefano Leporatti

Stefano Leporatti

6

0 references

Michele Maffia

14

Michele Maffia

1 reference

11 September 2017

Daniela Toraldo

3

1 reference

11 September 2017

Piero Del Boccio

4

1 reference

11 September 2017

Andrea Urbani

11

1 reference

11 September 2017

publication date

10 January 2012

1 reference

11 September 2017

1 reference

11 September 2017

volume

8

1 reference

11 September 2017

issue

4

1 reference

11 September 2017

page(s)

1078-1087

1 reference

11 September 2017

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

21 January 2018

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

Beyond chemotherapy: targeted therapies in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

The biology of ovarian cancer: new opportunities for translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

Nutrition and cancer: a review of the evidence for an anti-cancer diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

Nutrition and cancer: essential elements for a roadmap

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

Inhibition of carcinogenesis by dietary polyphenolic compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

Cancer chemoprevention with dietary phytochemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

Molecular targets of dietary agents for prevention and therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

Sensitization for anticancer drug-induced apoptosis by the chemopreventive agent resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

Resveratrol inhibits the epidermal growth factor-induced epithelial mesenchymal transition in MCF-7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

Resveratrol-induced autophagocytosis in ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

Resveratrol suppresses growth of human ovarian cancer cells in culture and in a murine xenograft model: eukaryotic elongation factor 1A2 as a potential target

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

Inducible COX-2-dependent apoptosis in human ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

trans-3,4,5'-Trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

Primary culture of ovarian surface epithelial cells and ascites-derived ovarian cancer cells from patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

IFN-beta reverses the lipopolysaccharide-induced proteome modifications in treated astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

PIK3CA is implicated as an oncogene in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

Overexpression of cyclin D1 is associated with poor survival in epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

Cyclin D as a therapeutic target in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

Activated MEK stimulates expression of AP-1 components independently of phosphatidylinositol 3-kinase (PI3-kinase) but requires a PI3-kinase signal To stimulate DNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kinase 4 (CDK4) and its phosphorylation by CDK-activating kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

Targeting p38 MAPK inhibits multiple myeloma cell growth in the bone marrow milieu

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

Single and combined silencing of ERK1 and ERK2 reveals their positive contribution to growth signaling depending on their expression levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

Modulation of survival pathways in ovarian carcinoma cell lines resistant to platinum compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

The role of ERK 1/2 and p38 MAP-kinase pathways in taxol-induced apoptosis in human ovarian carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

Proteins of the ADF/cofilin family: essential regulators of actin dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

Induction of apoptosis in Jeko-1 mantle cell lymphoma cell line by resveratrol: a proteomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

Phosphoinositide 3-kinase-mediated activation of cofilin phosphatase Slingshot and its role for insulin-induced membrane protrusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

C-terminal truncation of the retinoblastoma gene product leads to functional inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

The expression and significance of IDH1 and p53 in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

Endogenous p21WAF1/CIP1 status predicts the response of human tumor cells to wild-type p53 and p21WAF1/CIP1 overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

Phytochemicals in cancer prevention and therapy: truth or dare?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

Use of resveratrol to improve the effectiveness of cisplatin and doxorubicin: study in human gynecologic cancer cell lines and in rodent heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

Proteomic map of peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB05486H

21 January 2018

Identifiers

DOI

10.1039/C2MB05486H

1 reference

11 September 2017

1 reference